Acquired haemophilia A after stem cell transplant for sickle cell disease: treatment with recombinant porcine factor VIII (OBI-1) and tolerance induction with rituximab/prednisone.
作者信息
Lozier J N, Nghiem K, Lee M, Hodsdon B, Joe G, P Weitzel R, Tisdale J F, Hsieh M
机构信息
Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, MD, USA.
出版信息
Haemophilia. 2014 Mar;20(2):e185-8. doi: 10.1111/hae.12372.
Abstract
摘要
相似文献
1
Acquired haemophilia A after stem cell transplant for sickle cell disease: treatment with recombinant porcine factor VIII (OBI-1) and tolerance induction with rituximab/prednisone.镰状细胞病干细胞移植后获得性甲型血友病：用重组猪因子VIII（OBI-1）治疗及用利妥昔单抗/泼尼松诱导耐受
Haemophilia. 2014 Mar;20(2):e185-8. doi: 10.1111/hae.12372.
2
[Bullous pemphigoid and acquired haemophilia].[大疱性类天疱疮与获得性血友病]
Ann Dermatol Venereol. 2011 May;138(5):422-3. doi: 10.1016/j.annder.2011.01.040. Epub 2011 Mar 11.
3
Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature.利妥昔单抗未能诱导一名重度甲型血友病男孩产生免疫耐受并伴有同种免疫性凝血因子 VIII 抗体：病例报告及文献综述
Haemophilia. 2006 May;12(3):280-4. doi: 10.1111/j.1365-2516.2006.01212.x.
4
Inhibitor eradication with rituximab in haemophilia: where do we stand?利妥昔单抗在血友病中清除抑制剂：我们处于什么位置？
Br J Haematol. 2014 Jun;165(5):600-8. doi: 10.1111/bjh.12829. Epub 2014 Mar 15.
5
Acquired haemophilia A in a patient with systemic sclerosis treated with autologous haematopoietic stem cell transplantation.
Rheumatology (Oxford). 2015 Jan;54(1):196-7. doi: 10.1093/rheumatology/keu402. Epub 2014 Oct 6.
6
Rituximab for the treatment of high titre inhibitors in mild haemophilia A.利妥昔单抗用于治疗轻度甲型血友病中的高滴度抑制物。
Blood Transfus. 2014 Jan;12 Suppl 1(Suppl 1):s345-7. doi: 10.2450/2013.0229-12. Epub 2013 Feb 28.
7
Rituximab as first-line treatment for the management of adult patients with non-severe hemophilia A and inhibitors.利妥昔单抗作为非重型血友病 A 伴抑制物成人患者一线治疗药物。
J Thromb Haemost. 2014 Jun;12(6):897-901. doi: 10.1111/jth.12579.
8
Successful treatment of refractory autoimmune hemolytic anemia with monthly rituximab following nonmyeloablative stem cell transplantation for sickle cell disease.镰状细胞病非清髓性干细胞移植后每月使用利妥昔单抗成功治疗难治性自身免疫性溶血性贫血。
J Pediatr Hematol Oncol. 2004 May;26(5):312-4. doi: 10.1097/00043426-200405000-00011.
9
Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A.重组猪序列抗血友病因子VIII（OBI-1）在获得性血友病A患者中的疗效和安全性。
Haemophilia. 2015 Mar;21(2):162-170. doi: 10.1111/hae.12627. Epub 2015 Jan 27.
10
[Acquired haemophilia A: two cases].[获得性甲型血友病：两例]
Ann Dermatol Venereol. 2014 Jun-Jul;141(6-7):441-5. doi: 10.1016/j.annder.2014.03.012. Epub 2014 Apr 8.
引用本文的文献
1
Acquired hemophilia A following allogeneic stem cell transplantation for acute lymphoblastic leukemia.急性淋巴细胞白血病异基因造血干细胞移植后获得性血友病A
Ann Hematol. 2022 Aug;101(8):1861-1863. doi: 10.1007/s00277-022-04819-6. Epub 2022 Mar 21.
2
Rituximab for eradicating inhibitors in people with acquired haemophilia A.利妥昔单抗治疗获得性血友病 A 患者的抑制剂
Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD011907. doi: 10.1002/14651858.CD011907.pub3.
3
[Post-transplantation lymphoproliferative disorder accompanies acquired hemophilia after haploid hematopoietic stem cell transplantation in a pediatric AML patient: a case report and literature review].[儿童急性髓系白血病患者单倍体造血干细胞移植后移植后淋巴细胞增殖性疾病伴获得性血友病：一例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2019 Aug 14;40(8):691-693. doi: 10.3760/cma.j.issn.0253-2727.2019.08.015.
4
Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies.猪重组因子 VIII：应对抗因子 VIII 抗体的另一种手段。
Blood Transfus. 2017 Jul;15(4):365-368. doi: 10.2450/2016.0030-16. Epub 2016 Jul 25.
5
Rituximab for eradicating inhibitors in people with acquired haemophilia A.利妥昔单抗用于清除获得性甲型血友病患者体内的抑制物。
Cochrane Database Syst Rev. 2016 Jul 8;7(7):CD011907. doi: 10.1002/14651858.CD011907.pub2.
本文引用的文献
1
Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.健康个体和不同血友病 A 患者队列中针对因子 VIII 的抗体反应的特征不同。
Blood. 2013 Feb 7;121(6):1039-48. doi: 10.1182/blood-2012-07-444877. Epub 2012 Dec 12.
2
Acquired haemophilia caused by non-haemophilic factor VIII gene variants.由非血友病因子 VIII 基因变异引起的获得性血友病。
Ann Hematol. 2010 Jun;89(6):607-12. doi: 10.1007/s00277-009-0887-3. Epub 2010 Jan 7.
3
Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.异体造血干细胞移植治疗镰状细胞病。
N Engl J Med. 2009 Dec 10;361(24):2309-17. doi: 10.1056/NEJMoa0904971.
4
Inhibitors of factor VIII in black patients with hemophilia.黑人血友病患者中凝血因子VIII抑制剂
N Engl J Med. 2009 Apr 16;360(16):1618-27. doi: 10.1056/NEJMoa075760.
5
Quantitation of anti-factor VIII antibodies in human plasma.人血浆中抗凝血因子 VIII 抗体的定量分析。
Blood. 2009 Mar 12;113(11):2587-94. doi: 10.1182/blood-2008-08-174987. Epub 2009 Jan 14.
6
7
Use of porcine factor VIII in the treatment of patients with acquired hemophilia.
Blood. 1993 Mar 15;81(6):1513-20.
8
Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals.健康个体中针对凝血因子VIII（抗血友病因子）的天然抗体。
Proc Natl Acad Sci U S A. 1992 May 1;89(9):3795-9. doi: 10.1073/pnas.89.9.3795.
Zotero 插件